Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A
- PMID: 19443570
- DOI: 10.1210/en.2009-0377
Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A
Abstract
A variety of human malignancies overexpresses isoform A of the insulin receptor (IR-A) and produces IGFs (IGF-I and/or IGF-II). IR-A binds IGF-II with high affinity (although 4-fold lower than that for insulin), whereas it binds IGF-I with low affinity (approximately 30-fold lower than that for insulin). However, in engineered cells expressing only the IR-A, but not IGF-I receptor (R(-)/IR-A cells), IGF-II is a more potent mitogen than insulin. Herein, we investigated downstream signaling of IGF-II, IGF-I, and insulin in R(-)/IR-A cells to better understand their role in cell growth. We found that despite inducing a lower IR-A autophosphorylation than insulin, IGF-II was more potent than insulin for activating p70S6 kinase (p70S6K) and approximately equally potent in activating the early peaks of ERK1/2 and Akt. However, ERK1/2 activation persisted longer after IGF-II, whereas Akt activation persisted longer after insulin. Therefore, cells stimulated with IGF-II had a higher p70S6K/Akt activation ratio than cells stimulated with insulin. Remarkably, IGF-I also elicited a similar signaling pattern as IGF-II, despite inducing minimal IR-A autophosphorylation. ERK1/2 and protein kinase C seem to be involved in the preferential stimulation of p70S6K by IGFs. In conclusion, our study has identified a novel complex role of IR-A, which not only elicits a unique signaling pattern after IGF-II binding but also induces substantial downstream signaling upon binding to the low-affinity ligand IGF-I. These results underline the role of IR-A in physiology and disease.
Similar articles
-
Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.Endocrinology. 2003 Feb;144(2):581-93. doi: 10.1210/en.2002-220828. Endocrinology. 2003. PMID: 12538620
-
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.J Biol Chem. 2002 Oct 18;277(42):39684-95. doi: 10.1074/jbc.M202766200. Epub 2002 Jul 22. J Biol Chem. 2002. PMID: 12138094
-
Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line.Endocrinology. 2010 Sep;151(9):4197-206. doi: 10.1210/en.2009-1472. Epub 2010 Jun 23. Endocrinology. 2010. PMID: 20573722
-
Insulin and IGF-I receptor signaling in cultured neurons.Ann N Y Acad Sci. 1993 Aug 27;692:72-88. doi: 10.1111/j.1749-6632.1993.tb26207.x. Ann N Y Acad Sci. 1993. PMID: 8215046 Review.
-
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.Endocr Rev. 2009 Oct;30(6):586-623. doi: 10.1210/er.2008-0047. Epub 2009 Sep 14. Endocr Rev. 2009. PMID: 19752219 Review.
Cited by
-
Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A.J Biol Chem. 2012 Mar 30;287(14):11422-36. doi: 10.1074/jbc.M111.252478. Epub 2012 Feb 8. J Biol Chem. 2012. PMID: 22318726 Free PMC article.
-
Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances.Front Endocrinol (Lausanne). 2012 Feb 28;3:34. doi: 10.3389/fendo.2012.00034. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22649417 Free PMC article.
-
Insulin Receptor Isoforms in Physiology and Disease: An Updated View.Endocr Rev. 2017 Oct 1;38(5):379-431. doi: 10.1210/er.2017-00073. Endocr Rev. 2017. PMID: 28973479 Free PMC article. Review.
-
Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.Oncotarget. 2015 Jun 30;6(18):16084-105. doi: 10.18632/oncotarget.3177. Oncotarget. 2015. PMID: 25840417 Free PMC article.
-
Ligand-Binding Affinity at the Insulin Receptor Isoform-A and Subsequent IR-A Tyrosine Phosphorylation Kinetics are Important Determinants of Mitogenic Biological Outcomes.Front Endocrinol (Lausanne). 2015 Jul 7;6:107. doi: 10.3389/fendo.2015.00107. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26217307 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous